Results for Phase 1 Randomized Controlled Trial of MDMA and Fear Extinction Retention in Healthy Adults Published in Psychopharmacology

On February 15, 2022, the results of the MAPS-sponsored study by Barbara Rothbaum and team at Emory University evaluating MDMA on the startle response in healthy adults was published in the medical journal Psychopharmacology. This randomized, blinded, placebo-controlled Phase 1 mechanism of action study investigated the effects of MDMA on startle testing learning in healthy volunteers in comparison to a placebo control. Visit the study’s webpage to learn more and view a timeline of the study’s history.